Changes in Serum Calcitonin Concentrations, Incidence of Medullary Thyroid Carcinoma, and Impact of Routine Calcitonin Concentration Monitoring in the EXenatide Study of Cardiovascular Event Lowering (EXSCEL)

OBJECTIVE: Increases in serum calcitonin, a tumor marker for medullary thyroid carcinoma (MTC), have been associated with glucagon-like peptide 1 receptor agonist use in some preclinical studies. We report calcitonin changes in exenatide-treated and placebo-administered participants and MTC incidenc...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Diabetes Care
Main Authors: Bethel, M. Angelyn, Patel, Rishi A., Thompson, Vivian P., Merrill, Peter, Reed, Shelby D., Li, Yanhong, Ahmadi, Sara, Katona, Brian G., Gustavson, Stephanie M., Ohman, Peter, Iqbal, Nayyar, Gagel, Robert F., Hernandez, Adrian F., Buse, John B., Holman, Rury R.
Formato: Artigo
Idioma:Inglês
Publicado em: American Diabetes Association 2019
Assuntos:
Emerging Therapies: Drugs and Regimens
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6973544/
https://ncbi.nlm.nih.gov/pubmed/31010875
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc18-2028
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados